New Paradigm in Treating Cancer: Right on Target

Authors

  • Noorwati Sutandyo Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dharmais Cancer Center, Jakarta, Indonesia

Keywords:

anticancer therapy, monoclonal antibodies, targeted therapy, tyrosine kinase inhibitors

Abstract

Cancer prevalence is increasing every year and now cancer is the third highest cause of death in developing countries. Effective anticancer treatment can prolong life and improve the patient’s quality of life. Targeted therapy is a new therapeutic modality which targets specific molecules in the cancer cell and disrupts dysregulated signaling pathways involved in carcinogenesis. Since targeted therapy does not attack normal cells, its side effects are considered low compared to chemotherapy. More than 15 drugs have been approved for treatment in various human cancers. These drugs can largely be grouped into tyrosine kinase inhibitors and monoclonal antibodies. This review will focus on the most common agents within both groups.

Downloads

Published

2016-09-21

How to Cite

Sutandyo, N. (2016). New Paradigm in Treating Cancer: Right on Target. Acta Medica Indonesiana, 48(2), 139-144. Retrieved from https://mail.actamedindones.org/index.php/ijim/article/view/153

Issue

Vol. 48 No. 2 (2016): Acta Medica Indonesiana

Section

REVIEW ARTICLE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.